LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS

LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS was reported 7905 times

LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPERKALIURIA 5 0.0926
1 INTESTINAL ANGIOEDEMA 6 0.0125
2 KERATOACANTHOMA 8 0.0117
3 MILK-ALKALI SYNDROME 5 0.0096
4 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 9 0.0085
5 ANGIOEDEMA 262 0.0059
6 BUNDLE BRANCH BLOCK 5 0.0053
7 CARBOHYDRATE ANTIGEN 15-3 INCREASED 4 0.0053
8 BLADDER PROLAPSE 6 0.0049
9 HYPOAESTHESIA FACIAL 7 0.0047
10 ESSENTIAL HYPERTENSION 8 0.0044
11 PANCREATITIS NECROTISING 10 0.0043
12 ACUTE PRERENAL FAILURE 5 0.0043
13 THERAPEUTIC AGENT TOXICITY 13 0.0039
14 DIABETIC NEUROPATHY 19 0.0038
15 EYE CONTUSION 8 0.0038
16 METABOLIC ALKALOSIS 6 0.0037
17 ANION GAP INCREASED 5 0.0037
18 JOINT NOISE 7 0.0036
19 NEPHROGENIC ANAEMIA 16 0.0035
20 EYELID PAIN 7 0.0034
21 HYPOVOLAEMIA 20 0.0034
22 RECALLED PRODUCT ADMINISTERED 30 0.0031
23 ANGIONEUROTIC OEDEMA 8 0.0030
24 AGORAPHOBIA 4 0.0029
25 ORAL INTAKE REDUCED 7 0.0029
26 BODY TEMPERATURE ABNORMAL 5 0.0027
27 PROTEIN TOTAL INCREASED 7 0.0026
28 READING DISORDER 6 0.0026
29 BRONCHIAL DISORDER 4 0.0026
30 PRE-EXISTING CONDITION IMPROVED 16 0.0026
31 ATRIOVENTRICULAR BLOCK FIRST DEGREE 11 0.0025
32 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 6 0.0024
33 RENAL FAILURE ACUTE 103 0.0024
34 COLONIC POLYP 4 0.0024
35 LUNG NEOPLASM 10 0.0023
36 SENSATION OF HEAVINESS 9 0.0023
37 SARCOIDOSIS 11 0.0023
38 REBOUND ACID HYPERSECRETION 7 0.0023
39 RADICULOPATHY 6 0.0023
40 DIZZINESS POSTURAL 22 0.0023
41 RHINITIS ALLERGIC 10 0.0022
42 BREAST SWELLING 6 0.0022
43 SWOLLEN TONGUE 69 0.0022
44 ORTHOPNOEA 7 0.0022
45 BLOOD PRESSURE INADEQUATELY CONTROLLED 13 0.0022
46 BLADDER SPASM 4 0.0021
47 HIGH DENSITY LIPOPROTEIN DECREASED 7 0.0021
48 CLAVICLE FRACTURE 8 0.0021
49 HYPERPARATHYROIDISM SECONDARY 5 0.0020
50 INTERNATIONAL NORMALISED RATIO DECREASED 8 0.0020
51 BLOOD CHLORIDE DECREASED 5 0.0019
52 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 8 0.0019
53 THROMBOCYTOSIS 7 0.0019
54 SEASONAL ALLERGY 27 0.0019
55 OVERWEIGHT 10 0.0019
56 BLOOD TESTOSTERONE INCREASED 4 0.0019
57 RENAL CELL CARCINOMA 9 0.0018
58 BLOOD SODIUM DECREASED 34 0.0018
59 COMPUTERISED TOMOGRAM ABNORMAL 4 0.0018
60 AZOTAEMIA 7 0.0018
61 REGURGITATION 6 0.0017
62 COELIAC DISEASE 17 0.0017
63 PARAPLEGIA 5 0.0017
64 ECONOMIC PROBLEM 26 0.0017
65 FLUSHING 174 0.0017
66 VITAMIN D DEFICIENCY 16 0.0016
67 BREAST MASS 11 0.0016
68 BREATH SOUNDS ABNORMAL 8 0.0016
69 FLUID INTAKE REDUCED 8 0.0016
70 NON-CARDIAC CHEST PAIN 5 0.0016
71 BLADDER PAIN 5 0.0016
72 DIABETIC COMPLICATION 4 0.0016
73 PHARYNGEAL OEDEMA 24 0.0016
74 BLOOD UREA INCREASED 26 0.0016
75 OEDEMA MOUTH 5 0.0015
76 PROSTATOMEGALY 6 0.0015
77 HYPOAESTHESIA ORAL 23 0.0015
78 HYPERLIPIDAEMIA 18 0.0015
79 LIP SWELLING 50 0.0015
80 LACERATION 14 0.0015
81 RESTLESS LEGS SYNDROME 27 0.0015
82 SKIN ABRASION 7 0.0015
83 HYPONATRAEMIA 83 0.0015
84 HOT FLUSH 111 0.0015
85 PULSE ABSENT 7 0.0015
86 MENISCUS INJURY 9 0.0015
87 WOUND COMPLICATION 5 0.0015
88 ASTHENOPIA 8 0.0015
89 TYPE 2 DIABETES MELLITUS 49 0.0015
90 APHAGIA 7 0.0015
91 BLOOD CREATININE ABNORMAL 5 0.0014
92 TACHYPHRENIA 5 0.0014
93 CHOLECYSTITIS INFECTIVE 4 0.0014
94 BLOOD POTASSIUM DECREASED 43 0.0014
95 ABNORMAL DREAMS 39 0.0014
96 FRUSTRATION 5 0.0014
97 GOUT 25 0.0014
98 HEPATIC LESION 6 0.0014
99 ANGINA UNSTABLE 9 0.0014
100 SLEEP APNOEA SYNDROME 26 0.0014
101 BENIGN PROSTATIC HYPERPLASIA 7 0.0014
102 ALCOHOL USE 5 0.0014
103 GLUCOSE TOLERANCE IMPAIRED 8 0.0014
104 ARTHROPOD BITE 10 0.0013
105 SINUS BRADYCARDIA 13 0.0013
106 CHOLECYSTITIS CHRONIC 9 0.0013
107 THINKING ABNORMAL 25 0.0013
108 BLOOD CULTURE POSITIVE 4 0.0013
109 ANORECTAL DISCOMFORT 7 0.0013
110 RENAL FAILURE CHRONIC 10 0.0013
111 LACTIC ACIDOSIS 42 0.0013
112 RENAL FUNCTION TEST ABNORMAL 6 0.0013
113 OLIGURIA 8 0.0013
114 FEELING HOT 79 0.0013
115 VITAMIN D DECREASED 11 0.0013
116 FLANK PAIN 12 0.0013
117 DEHYDRATION 170 0.0013
118 SPINAL COLUMN STENOSIS 6 0.0013
119 DIVERTICULUM 9 0.0013
120 GINGIVAL PAIN 10 0.0013
121 TOXIC EPIDERMAL NECROLYSIS 19 0.0012
122 CANDIDIASIS 5 0.0012
123 POOR QUALITY DRUG ADMINISTERED 8 0.0012
124 HYPOKALAEMIA 57 0.0012
125 BACK DISORDER 20 0.0012
126 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 5 0.0012
127 PERIPHERAL VENOUS DISEASE 5 0.0012
128 GOITRE 5 0.0012
129 HUNGER 17 0.0012
130 SMALL INTESTINAL OBSTRUCTION 15 0.0012
131 HOSPICE CARE 12 0.0012
132 EXPIRED DRUG ADMINISTERED 6 0.0012
133 PULSELESS ELECTRICAL ACTIVITY 5 0.0012
134 PHARMACEUTICAL PRODUCT COMPLAINT 31 0.0012
135 PEMPHIGOID 9 0.0012
136 OBESITY 19 0.0012
137 INTERVERTEBRAL DISC DEGENERATION 11 0.0012
138 WOUND INFECTION 13 0.0012
139 HAEMORRHOIDS 23 0.0012
140 MIDDLE INSOMNIA 22 0.0012
141 POOR PERIPHERAL CIRCULATION 5 0.0012
142 CARBOHYDRATE ANTIGEN 125 INCREASED 4 0.0012
143 RETCHING 25 0.0012
144 INTERVERTEBRAL DISC DISORDER 5 0.0012
145 PROTHROMBIN TIME PROLONGED 7 0.0012
146 ARTERIOSCLEROSIS 11 0.0012
147 SQUAMOUS CELL CARCINOMA 11 0.0012
148 FOOD ALLERGY 9 0.0012
149 LOW DENSITY LIPOPROTEIN INCREASED 9 0.0012
150 SQUAMOUS CELL CARCINOMA OF SKIN 7 0.0012
151 BLOOD PRESSURE ABNORMAL 23 0.0012
152 BASAL CELL CARCINOMA 18 0.0012
153 EYE PAIN 65 0.0012
154 POLLAKIURIA 48 0.0011
155 MULTIPLE ALLERGIES 9 0.0011
156 CARPAL TUNNEL SYNDROME 16 0.0011
157 HYPERCHOLESTEROLAEMIA 11 0.0011
158 BLOOD PRESSURE INCREASED 174 0.0011
159 THERMAL BURN 8 0.0011
160 BODY HEIGHT DECREASED 12 0.0011
161 RENAL TUBULAR NECROSIS 11 0.0011
162 APPENDICECTOMY 4 0.0011
163 MENTAL STATUS CHANGES 31 0.0011
164 PRURITUS GENERALISED 24 0.0011
165 TONGUE DISORDER 8 0.0011
166 MUSCULOSKELETAL DISCOMFORT 19 0.0011
167 UTERINE LEIOMYOMA 8 0.0011
168 DRUG LEVEL ABOVE THERAPEUTIC 5 0.0011
169 GASTROINTESTINAL PAIN 12 0.0011
170 ISCHAEMIA 5 0.0011
171 CARDIAC FLUTTER 7 0.0011
172 BLOOD CHOLESTEROL ABNORMAL 5 0.0011
173 LOWER GASTROINTESTINAL HAEMORRHAGE 8 0.0011
174 NERVE INJURY 12 0.0011
175 ARTHRITIS INFECTIVE 5 0.0011
176 JOINT INJURY 23 0.0011
177 FEELING DRUNK 8 0.0011
178 DIABETES MELLITUS INADEQUATE CONTROL 19 0.0011
179 GASTRITIS EROSIVE 5 0.0011
180 ORAL PAIN 24 0.0011
181 EAR DISCOMFORT 11 0.0011
182 COUGH 298 0.0011
183 ACTIVITIES OF DAILY LIVING IMPAIRED 21 0.0011
184 APPETITE DISORDER 7 0.0011
185 HAIR COLOUR CHANGES 13 0.0010
186 INCONTINENCE 11 0.0010
187 CARDIAC MURMUR 9 0.0010
188 BLOOD URIC ACID INCREASED 6 0.0010
189 WRONG PRODUCT ADMINISTERED 7 0.0010
190 GUILLAIN-BARRE SYNDROME 5 0.0010
191 HAEMORRHOIDAL HAEMORRHAGE 5 0.0010
192 FEELING OF BODY TEMPERATURE CHANGE 6 0.0010
193 ECCHYMOSIS 7 0.0010
194 BLOOD TRIGLYCERIDES INCREASED 18 0.0010
195 BLADDER DISORDER 10 0.0010
196 CARDIAC PACEMAKER INSERTION 6 0.0010
197 HYPERTENSION 213 0.0010
198 HIATUS HERNIA 13 0.0010
199 HYPERKALAEMIA 35 0.0010
200 BLEPHARITIS 4 0.0010
201 FEELING JITTERY 19 0.0010
202 GLYCOSYLATED HAEMOGLOBIN INCREASED 25 0.0010
203 DIALYSIS 14 0.0010
204 EXOSTOSIS 9 0.0010
205 HYPOPHAGIA 25 0.0010
206 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 5 0.0010
207 CHRONIC KIDNEY DISEASE 74 0.0010
208 TEMPERATURE INTOLERANCE 10 0.0010
209 IMPAIRED DRIVING ABILITY 11 0.0010
210 SCAB 11 0.0010
211 APPENDICITIS 9 0.0010
212 SYNCOPE 96 0.0010
213 ANHEDONIA 25 0.0010
214 SKIN LESION 26 0.0009
215 POST PROCEDURAL HAEMORRHAGE 11 0.0009
216 RESPIRATORY TRACT CONGESTION 15 0.0009
217 PARAESTHESIA 148 0.0009
218 FEEDING DISORDER 19 0.0009
219 RHABDOMYOLYSIS 39 0.0009
220 HYDRONEPHROSIS 7 0.0009
221 ABNORMAL SENSATION IN EYE 4 0.0009
222 FEAR 25 0.0009
223 ACUTE KIDNEY INJURY 142 0.0009
224 PSYCHOLOGICAL TRAUMA 8 0.0009
225 HIP SURGERY 5 0.0009
226 BLOOD CHOLESTEROL INCREASED 43 0.0009
227 AGEUSIA 23 0.0009
228 TENDON DISORDER 6 0.0009
229 BRADYPHRENIA 6 0.0009
230 POLYP 6 0.0009
231 VITREOUS FLOATERS 9 0.0009
232 URINE OUTPUT DECREASED 8 0.0009
233 TOOTH INFECTION 12 0.0009
234 THYROID DISORDER 14 0.0009
235 INTESTINAL ISCHAEMIA 5 0.0009
236 COLD SWEAT 16 0.0009
237 BURSITIS 11 0.0009
238 HYPERKERATOSIS 5 0.0009
239 SWELLING FACE 59 0.0009
240 ANKLE FRACTURE 14 0.0009
241 PRODUCT SUBSTITUTION ISSUE 52 0.0009
242 FACIAL PAIN 8 0.0009
243 SPINAL OPERATION 11 0.0009
244 UPPER GASTROINTESTINAL HAEMORRHAGE 15 0.0009
245 HYPERCALCAEMIA 11 0.0009
246 DYSSTASIA 26 0.0009
247 STOMATITIS 54 0.0009
248 METASTASES TO LYMPH NODES 6 0.0009
249 MUSCLE SPASMS 163 0.0009
250 SINUS CONGESTION 12 0.0009
251 HEMIPARESIS 15 0.0009
252 BLOOD ALBUMIN DECREASED 7 0.0009
253 DIABETES MELLITUS 67 0.0009
254 INITIAL INSOMNIA 9 0.0009
255 DERMATITIS CONTACT 10 0.0009
256 FAECES DISCOLOURED 19 0.0009
257 BLOOD PRESSURE DECREASED 58 0.0009
258 SENSORY DISTURBANCE 14 0.0009
259 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
260 BURNING SENSATION 61 0.0009
261 UROSEPSIS 8 0.0009
262 NERVE COMPRESSION 8 0.0009
263 DIVERTICULITIS 24 0.0009
264 LARGE INTESTINE PERFORATION 6 0.0009
265 PRESYNCOPE 21 0.0009
266 FORMICATION 6 0.0009
267 RALES 5 0.0009
268 POST PROCEDURAL INFECTION 7 0.0009
269 SKIN WARM 5 0.0009
270 NEPHROPATHY 8 0.0009
271 ROTATOR CUFF SYNDROME 11 0.0009
272 ANOREXIA 11 0.0009
273 SCRATCH 9 0.0009
274 HAIR DISORDER 7 0.0008
275 OSTEOARTHRITIS 36 0.0008
276 DECREASED INTEREST 5 0.0008
277 LABORATORY TEST ABNORMAL 25 0.0008
278 BLOOD URINE PRESENT 16 0.0008
279 NERVOUSNESS 44 0.0008
280 SINUS HEADACHE 5 0.0008
281 INSOMNIA 224 0.0008
282 THERAPY INTERRUPTED 60 0.0008
283 CHOLECYSTITIS 10 0.0008
284 CONSTIPATION 183 0.0008
285 NIGHTMARE 29 0.0008
286 TASTE DISORDER 17 0.0008
287 GAIT INABILITY 28 0.0008
288 ODYNOPHAGIA 5 0.0008
289 THERAPY CESSATION 43 0.0008
290 RENAL FAILURE 111 0.0008
291 WRIST FRACTURE 10 0.0008
292 GASTROOESOPHAGEAL REFLUX DISEASE 67 0.0008
293 SENSATION OF FOREIGN BODY 7 0.0008
294 BRAIN FOG 13 0.0008
295 SKIN LACERATION 9 0.0008
296 BLOOD CREATININE INCREASED 54 0.0008
297 LOCALISED INFECTION 20 0.0008
298 WHEEZING 49 0.0008
299 BALANCE DISORDER 71 0.0008
300 MUSCULOSKELETAL PAIN 43 0.0008
301 HYPOTENSION 164 0.0008
302 GLOMERULAR FILTRATION RATE DECREASED 10 0.0008
303 DENTAL CARIES 9 0.0008
304 PANCREATITIS 43 0.0008
305 PRODUCT DOSE OMISSION IN ERROR 23 0.0008
306 VISION BLURRED 111 0.0008
307 HYSTERECTOMY 7 0.0008
308 HAEMATOCRIT DECREASED 16 0.0008
309 ABDOMINAL DISCOMFORT 135 0.0008
310 THERAPEUTIC RESPONSE UNEXPECTED 36 0.0008
311 CORONARY ARTERY OCCLUSION 11 0.0008
312 OCULAR DISCOMFORT 9 0.0008
313 SPEECH DISORDER 42 0.0008
314 PANCREATITIS ACUTE 18 0.0008
315 RESPIRATORY ARREST 22 0.0008
316 DIZZINESS 398 0.0008
317 HEART RATE IRREGULAR 18 0.0008
318 COMPLETED SUICIDE 66 0.0008
319 FOOT FRACTURE 15 0.0008
320 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 38 0.0008
321 CORONARY ARTERIAL STENT INSERTION 4 0.0008
322 MICTURITION URGENCY 9 0.0008
323 DYSKINESIA 32 0.0008
324 DRY THROAT 8 0.0008
325 TOOTH ABSCESS 8 0.0008
326 WRONG DRUG ADMINISTERED 7 0.0008
327 FOREIGN BODY SENSATION IN EYES 5 0.0008
328 GALLBLADDER DISORDER 14 0.0008
329 BRONCHITIS 58 0.0008
330 WHITE BLOOD CELL COUNT ABNORMAL 5 0.0008
331 HYPOGLYCAEMIA 38 0.0008
332 GASTROINTESTINAL INFECTION 7 0.0008
333 MYOSITIS 7 0.0008
334 NEUROPATHY PERIPHERAL 74 0.0008
335 CEREBRAL ISCHAEMIA 4 0.0008
336 URINARY INCONTINENCE 23 0.0008
337 ATRIOVENTRICULAR BLOCK 6 0.0008
338 NIGHT SWEATS 25 0.0008
339 GASTROENTERITIS VIRAL 14 0.0008
340 RENAL INJURY 23 0.0008
341 APHTHOUS ULCER 6 0.0008
342 FEELING ABNORMAL 185 0.0008
343 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 5 0.0008
344 BLOOD PRESSURE SYSTOLIC INCREASED 15 0.0008
345 RECTAL HAEMORRHAGE 33 0.0008
346 HYPERSOMNIA 22 0.0008
347 PAIN IN EXTREMITY 226 0.0008
348 DIARRHOEA 495 0.0008
349 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
350 PSORIATIC ARTHROPATHY 31 0.0008
351 SOMNAMBULISM 5 0.0008
352 HYPOAESTHESIA 114 0.0008
353 DRUG EFFECT DECREASED 41 0.0008
354 DISTURBANCE IN ATTENTION 41 0.0008
355 CORONARY ARTERY DISEASE 23 0.0008
356 WALKING AID USER 5 0.0008
357 INJECTION SITE HAEMATOMA 11 0.0008
358 BLOOD GLUCOSE ABNORMAL 14 0.0008
359 SINUS DISORDER 15 0.0008
360 MUSCULAR WEAKNESS 86 0.0008
361 TRICUSPID VALVE INCOMPETENCE 6 0.0008
362 MYOCLONUS 9 0.0008
363 EYE SWELLING 28 0.0008
364 ABSCESS 12 0.0008
365 CARDIAC ARREST 62 0.0008
366 HYPERHIDROSIS 96 0.0007
367 ASTHENIA 280 0.0007
368 RHINITIS 6 0.0007
369 FRUSTRATION TOLERANCE DECREASED 6 0.0007
370 DECREASED ACTIVITY 8 0.0007
371 COLITIS ISCHAEMIC 5 0.0007
372 ROAD TRAFFIC ACCIDENT 31 0.0007
373 TRANSIENT ISCHAEMIC ATTACK 25 0.0007
374 MUSCLE DISORDER 6 0.0007
375 FIBROMYALGIA 18 0.0007
376 BACK PAIN 172 0.0007
377 ERECTILE DYSFUNCTION 19 0.0007
378 VERTIGO 45 0.0007
379 BIPOLAR DISORDER 8 0.0007
380 DRUG TOXICITY 10 0.0007
381 OESOPHAGITIS 8 0.0007
382 INTERVERTEBRAL DISC PROTRUSION 16 0.0007
383 BLOOD TESTOSTERONE DECREASED 5 0.0007
384 EYE MOVEMENT DISORDER 5 0.0007
385 CROHN'S DISEASE 5 0.0007
386 ABASIA 18 0.0007
387 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
388 WEIGHT DECREASED 203 0.0007
389 PROSTATIC SPECIFIC ANTIGEN INCREASED 10 0.0007
390 CYST 9 0.0007
391 ARTHRITIS 57 0.0007
392 ATELECTASIS 7 0.0007
393 ACUTE CORONARY SYNDROME 6 0.0007
394 HERNIA 14 0.0007
395 ERUCTATION 14 0.0007
396 AMNESIA 47 0.0007
397 OEDEMA PERIPHERAL 88 0.0007
398 MOOD SWINGS 23 0.0007
399 ORAL DISCOMFORT 10 0.0007
400 OBSTRUCTIVE AIRWAYS DISORDER 8 0.0007
401 HIP ARTHROPLASTY 11 0.0007
402 DYSPHONIA 42 0.0007
403 COORDINATION ABNORMAL 10 0.0007
404 DYSPHAGIA 68 0.0007
405 FALL 238 0.0007
406 ANGIOPATHY 4 0.0007
407 SKIN INFECTION 8 0.0007
408 ACUTE MYOCARDIAL INFARCTION 21 0.0007
409 DYSPEPSIA 70 0.0007
410 BLINDNESS UNILATERAL 10 0.0007
411 INFLUENZA LIKE ILLNESS 58 0.0007
412 PSORIASIS 92 0.0007
413 FATIGUE 548 0.0007
414 MENTAL IMPAIRMENT 17 0.0007
415 RASH PRURITIC 38 0.0007
416 SURGERY 41 0.0007
417 NAUSEA 553 0.0007
418 HEPATIC STEATOSIS 13 0.0007
419 STAPHYLOCOCCAL INFECTION 23 0.0007
420 POOR QUALITY SLEEP 15 0.0007
421 CORONARY ARTERY BYPASS 4 0.0007
422 HEAD INJURY 22 0.0007
423 MYOPATHY 6 0.0007
424 MULTI-ORGAN FAILURE 12 0.0007
425 PRODUCT PHYSICAL ISSUE 14 0.0007
426 URINARY TRACT INFECTION 118 0.0007
427 DERMATITIS BULLOUS 5 0.0007
428 URINARY RETENTION 23 0.0007
429 MADAROSIS 8 0.0007
430 HYPOTHYROIDISM 22 0.0007
431 WRONG TECHNIQUE IN DRUG USAGE PROCESS 25 0.0007
432 PERIPHERAL SWELLING 106 0.0007
433 FAECES SOFT 5 0.0007
434 MAJOR DEPRESSION 5 0.0007
435 GASTRITIS 18 0.0007
436 PULMONARY CONGESTION 9 0.0007
437 EMOTIONAL DISORDER 21 0.0007
438 LYMPHOCYTE COUNT DECREASED 12 0.0007
439 RENAL IMPAIRMENT 57 0.0007
440 BLINDNESS TRANSIENT 5 0.0007
441 DRY MOUTH 55 0.0007
442 BRADYKINESIA 4 0.0007
443 EYE IRRITATION 39 0.0007
444 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
445 ACUTE RESPIRATORY FAILURE 13 0.0007
446 BLOOD IRON DECREASED 8 0.0007
447 CATARACT OPERATION 4 0.0007
448 HAIR TEXTURE ABNORMAL 9 0.0007
449 PRURITUS 258 0.0007
450 JOINT RANGE OF MOTION DECREASED 9 0.0007
451 UPPER RESPIRATORY TRACT INFECTION 31 0.0007
452 GASTRIC DISORDER 23 0.0007
453 FOLLICULITIS 7 0.0007
454 CHOKING 13 0.0007
455 RED BLOOD CELL COUNT DECREASED 19 0.0007
456 ARTHRALGIA 276 0.0007
457 GAIT DISTURBANCE 127 0.0007
458 LEUKOCYTOSIS 12 0.0007
459 JOINT DISLOCATION 7 0.0007
460 CRYING 24 0.0007
461 TENDON PAIN 5 0.0007
462 NOCTURIA 8 0.0007
463 END STAGE RENAL DISEASE 12 0.0007
464 CHEST DISCOMFORT 67 0.0007
465 BOWEL MOVEMENT IRREGULARITY 5 0.0007
466 BLOOD THYROID STIMULATING HORMONE INCREASED 6 0.0007
467 SOMNOLENCE 131 0.0006
468 HYPOACUSIS 28 0.0006
469 JOINT STIFFNESS 17 0.0006
470 DRUG DOSE OMISSION 107 0.0006
471 ANXIETY 184 0.0006
472 LIMB DISCOMFORT 20 0.0006
473 MUSCULOSKELETAL CHEST PAIN 10 0.0006
474 DYSGEUSIA 48 0.0006
475 HEART RATE INCREASED 64 0.0006
476 PERSONALITY CHANGE 6 0.0006
477 CONCUSSION 5 0.0006
478 NECK PAIN 36 0.0006
479 BACK INJURY 7 0.0006
480 TOOTH EXTRACTION 8 0.0006
481 SCAR 11 0.0006
482 HAEMATURIA 22 0.0006
483 PELVIC FRACTURE 5 0.0006
484 DRY EYE 32 0.0006
485 HAEMORRHAGIC STROKE 5 0.0006
486 LOSS OF CONSCIOUSNESS 82 0.0006
487 PHOTOPHOBIA 12 0.0006
488 BLEPHAROSPASM 4 0.0006
489 PAIN 390 0.0006
490 RED BLOOD CELL SEDIMENTATION RATE INCREASED 7 0.0006
491 OCULAR HYPERAEMIA 30 0.0006
492 FOOT DEFORMITY 7 0.0006
493 MUSCLE ATROPHY 8 0.0006
494 VIRAL INFECTION 21 0.0006
495 TOOTH DISORDER 14 0.0006
496 EYE INFLAMMATION 6 0.0006
497 ANGINA PECTORIS 18 0.0006
498 BLOOD GLUCOSE INCREASED 118 0.0006
499 INTRAOCULAR PRESSURE INCREASED 8 0.0006
500 METABOLIC ACIDOSIS 20 0.0006
501 LOWER LIMB FRACTURE 12 0.0006
502 DRUG PRESCRIBING ERROR 12 0.0006
503 SINUSITIS 64 0.0006
504 PULMONARY HYPERTENSION 13 0.0006
505 CONTUSION 60 0.0006
506 BLOOD CALCIUM DECREASED 7 0.0006
507 INTENTIONAL DRUG MISUSE 13 0.0006
508 SENSORY LOSS 5 0.0006
509 HYPOKINESIA 9 0.0006
510 SKIN ULCER 16 0.0006
511 MUSCULOSKELETAL STIFFNESS 54 0.0006
512 CELLULITIS 31 0.0006
513 TREMOR 102 0.0006
514 INTERNAL HAEMORRHAGE 7 0.0006
515 CONFUSIONAL STATE 99 0.0006
516 MUCOSAL INFLAMMATION 16 0.0006
517 DYSPNOEA EXERTIONAL 23 0.0006
518 FEELING COLD 17 0.0006
519 NEPHROLITHIASIS 28 0.0006
520 ABNORMAL FAECES 5 0.0006
521 HYPERAESTHESIA 5 0.0006
522 EYE DISORDER 20 0.0006
523 MUSCLE TWITCHING 14 0.0006
524 WEIGHT INCREASED 136 0.0006
525 LIGAMENT SPRAIN 6 0.0006
526 BLISTER 34 0.0006
527 PANIC ATTACK 22 0.0006
528 PRESCRIBED UNDERDOSE 12 0.0006
529 PAIN IN JAW 17 0.0006
530 MYALGIA 102 0.0006
531 VOMITING 282 0.0006
532 DRUG INTERACTION 95 0.0006
533 CARDIAC FAILURE CONGESTIVE 48 0.0006
534 APHASIA 18 0.0006
535 LACRIMATION INCREASED 18 0.0006
536 FULL BLOOD COUNT DECREASED 12 0.0006
537 HAEMODIALYSIS 5 0.0006
538 EMPHYSEMA 6 0.0006
539 COVID-19 PNEUMONIA 7 0.0006
540 BACTERAEMIA 7 0.0006
541 SUBARACHNOID HAEMORRHAGE 6 0.0006
542 CHILLS 69 0.0006
543 TACHYPNOEA 8 0.0006
544 IMPAIRED GASTRIC EMPTYING 8 0.0006
545 MOOD ALTERED 16 0.0006
546 MACULAR DEGENERATION 7 0.0006
547 RIB FRACTURE 12 0.0006
548 PERIPHERAL COLDNESS 8 0.0006
549 MEMORY IMPAIRMENT 80 0.0006
550 UNEVALUABLE EVENT 44 0.0006
551 ANURIA 5 0.0006
552 GLOSSODYNIA 13 0.0006
553 DISORIENTATION 23 0.0006
554 DEPRESSION 132 0.0006
555 BLOOD MAGNESIUM DECREASED 5 0.0006
556 PYELONEPHRITIS 5 0.0006
557 DECREASED APPETITE 134 0.0006
558 CHROMATURIA 13 0.0006
559 PSYCHOTIC DISORDER 17 0.0006
560 HERPES ZOSTER 33 0.0006
561 ORTHOSTATIC HYPOTENSION 10 0.0006
562 LETHARGY 33 0.0006
563 WEIGHT FLUCTUATION 6 0.0006
564 LOCAL SWELLING 10 0.0006
565 TRANSFUSION 6 0.0006
566 DYSPNOEA 324 0.0006
567 WITHDRAWAL SYNDROME 24 0.0006
568 PRODUCT USE COMPLAINT 9 0.0006
569 HEART RATE DECREASED 20 0.0006
570 BLOOD TEST ABNORMAL 8 0.0006
571 SPINAL OSTEOARTHRITIS 5 0.0006
572 HALLUCINATION, AUDITORY 9 0.0006
573 SWELLING 53 0.0006
574 BRADYCARDIA 30 0.0006
575 HAEMOGLOBIN DECREASED 58 0.0006
576 HEAD DISCOMFORT 10 0.0006
577 PHARYNGITIS 7 0.0006
578 EATING DISORDER 12 0.0006
579 BREAST PAIN 6 0.0006
580 ANGER 19 0.0006
581 NASAL CONGESTION 33 0.0006
582 THIRST 10 0.0006
583 SKIN CANCER 12 0.0006
584 PAIN OF SKIN 15 0.0006
585 DERMATITIS ALLERGIC 7 0.0006
586 MUSCLE TIGHTNESS 9 0.0006
587 PALPITATIONS 65 0.0006
588 THROAT TIGHTNESS 15 0.0006
589 CATARACT 33 0.0006
590 DEEP VEIN THROMBOSIS 36 0.0006
591 ANOSMIA 8 0.0006
592 OROPHARYNGEAL PAIN 51 0.0006
593 MALAISE 241 0.0005
594 SPINAL FRACTURE 11 0.0005
595 BONE DISORDER 10 0.0005
596 GASTROENTERITIS 8 0.0005
597 EPISTAXIS 41 0.0005
598 BLOOD GLUCOSE FLUCTUATION 6 0.0005
599 BRAIN NEOPLASM 5 0.0005
600 TINNITUS 25 0.0005
601 ABDOMINAL PAIN UPPER 112 0.0005
602 HEADACHE 341 0.0005
603 INCREASED TENDENCY TO BRUISE 5 0.0005
604 INFUSION SITE PAIN 7 0.0005
605 IRON DEFICIENCY ANAEMIA 5 0.0005
606 DISCOMFORT 33 0.0005
607 FUNGAL INFECTION 18 0.0005
608 ANAEMIA 103 0.0005
609 PRODUCT DISTRIBUTION ISSUE 5 0.0005
610 DIPLOPIA 14 0.0005
611 PULMONARY MASS 8 0.0005
612 INTENTIONAL PRODUCT MISUSE 47 0.0005
613 COLON CANCER 8 0.0005
614 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 28 0.0005
615 ABDOMINAL DISTENSION 56 0.0005
616 MALNUTRITION 6 0.0005
617 CHEST PAIN 99 0.0005
618 BEDRIDDEN 7 0.0005
619 JOINT SWELLING 64 0.0005
620 SARS-COV-2 TEST POSITIVE 7 0.0005
621 ASPARTATE AMINOTRANSFERASE INCREASED 28 0.0005
622 CHOLECYSTECTOMY 6 0.0005
623 SUICIDAL IDEATION 48 0.0005
624 ATRIAL FIBRILLATION 51 0.0005
625 DRUG DISPENSING ERROR 8 0.0005
626 RASH ERYTHEMATOUS 25 0.0005
627 MALIGNANT MELANOMA 7 0.0005
628 GASTRIC HAEMORRHAGE 6 0.0005
629 PULMONARY FIBROSIS 10 0.0005
630 HALLUCINATION, VISUAL 11 0.0005
631 POST PROCEDURAL COMPLICATION 10 0.0005
632 CHOLELITHIASIS 17 0.0005
633 IMPAIRED HEALING 17 0.0005
634 PRESCRIBED OVERDOSE 10 0.0005
635 VISUAL IMPAIRMENT 64 0.0005
636 ELECTROLYTE IMBALANCE 6 0.0005
637 OEDEMA 28 0.0005
638 EYELID OEDEMA 6 0.0005
639 LIMB INJURY 14 0.0005
640 PRODUCT QUALITY ISSUE 70 0.0005
641 VASCULITIS 6 0.0005
642 RASH MACULAR 18 0.0005
643 IMPAIRED WORK ABILITY 11 0.0005
644 PARKINSONISM 5 0.0005
645 GINGIVAL BLEEDING 7 0.0005
646 INJURY 36 0.0005
647 SLEEP DISORDER 36 0.0005
648 ARTERIAL OCCLUSIVE DISEASE 4 0.0005
649 AFFECTIVE DISORDER 4 0.0005
650 CEREBROVASCULAR ACCIDENT 86 0.0005
651 COVID-19 89 0.0005
652 RESPIRATORY DISTRESS 14 0.0005
653 ABDOMINAL PAIN 118 0.0005
654 SYSTEMIC LUPUS ERYTHEMATOSUS 18 0.0005
655 ATAXIA 6 0.0005
656 PULMONARY EMBOLISM 48 0.0005
657 PRODUCT DISPENSING ERROR 11 0.0005
658 ISCHAEMIC STROKE 9 0.0005
659 AGITATION 37 0.0005
660 ARTHROPATHY 28 0.0005
661 UNRESPONSIVE TO STIMULI 13 0.0005
662 PRODUCTIVE COUGH 24 0.0005
663 ACCIDENT 6 0.0005
664 RASH GENERALISED 13 0.0005
665 MULTIPLE SCLEROSIS 24 0.0005
666 SCIATICA 8 0.0005
667 BLOOD PRESSURE FLUCTUATION 12 0.0005
668 BLOOD GLUCOSE DECREASED 24 0.0005
669 IRRITABILITY 30 0.0005
670 PLATELET COUNT DECREASED 53 0.0005
671 TOOTHACHE 9 0.0005
672 WHITE BLOOD CELL COUNT INCREASED 19 0.0005
673 NEURALGIA 12 0.0005
674 SINUS TACHYCARDIA 7 0.0005
675 BLOOD POTASSIUM INCREASED 8 0.0005
676 INTERNATIONAL NORMALISED RATIO INCREASED 14 0.0005
677 DECUBITUS ULCER 4 0.0005
678 MOTOR DYSFUNCTION 5 0.0005
679 SLUGGISHNESS 5 0.0005
680 DYSURIA 18 0.0005
681 EAR INFECTION 13 0.0005
682 MUSCLE SPASTICITY 6 0.0005
683 CARDIOMEGALY 6 0.0005
684 INFLAMMATION 25 0.0005
685 BACTERIAL INFECTION 9 0.0005
686 RESPIRATORY FAILURE 35 0.0005
687 RHINORRHOEA 31 0.0005
688 SKIN DISCOLOURATION 22 0.0005
689 GASTROINTESTINAL HAEMORRHAGE 40 0.0005
690 DYSARTHRIA 18 0.0005
691 PALLOR 13 0.0005
692 POISONING 6 0.0005
693 PRODUCT ODOUR ABNORMAL 5 0.0005
694 FLATULENCE 27 0.0005
695 KNEE ARTHROPLASTY 10 0.0005
696 HAEMATEMESIS 12 0.0005
697 RENAL PAIN 5 0.0005
698 INJECTION SITE IRRITATION 6 0.0005
699 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 8 0.0005
700 WHITE BLOOD CELL COUNT DECREASED 51 0.0005
701 IMMUNODEFICIENCY 7 0.0005
702 DRUG EFFECT INCOMPLETE 17 0.0005
703 ERYTHEMA 96 0.0005
704 HYPERGLYCAEMIA 17 0.0005
705 URTICARIA 78 0.0005
706 DEMENTIA 13 0.0005
707 RESTLESSNESS 17 0.0005
708 PARANOIA 8 0.0005
709 INJECTION SITE INDURATION 6 0.0005
710 SKIN BURNING SENSATION 33 0.0005
711 KIDNEY INFECTION 9 0.0005
712 PULMONARY THROMBOSIS 5 0.0005
713 ALOPECIA 90 0.0005
714 DIABETIC KETOACIDOSIS 11 0.0005
715 ASPIRATION 5 0.0005
716 BLOOD CALCIUM INCREASED 4 0.0005
717 INTENTIONAL DOSE OMISSION 13 0.0005
718 ORAL CANDIDIASIS 6 0.0005
719 METASTASES TO LIVER 8 0.0005
720 CONVULSION 26 0.0005
721 RASH 198 0.0005
722 HAEMATOCHEZIA 25 0.0005
723 FLUID RETENTION 23 0.0005
724 TENDONITIS 7 0.0005
725 DELUSION 7 0.0005
726 EYE HAEMORRHAGE 6 0.0004
727 THROMBOSIS 36 0.0004
728 LIVER FUNCTION TEST ABNORMAL 13 0.0004
729 CEREBRAL HAEMORRHAGE 16 0.0004
730 PULMONARY OEDEMA 20 0.0004
731 PRODUCT ADMINISTRATION ERROR 9 0.0004
732 BLOOD BILIRUBIN INCREASED 12 0.0004
733 PRODUCT TASTE ABNORMAL 6 0.0004
734 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
735 MYOCARDIAL INFARCTION 77 0.0004
736 RHEUMATOID ARTHRITIS 50 0.0004
737 ULCER 7 0.0004
738 ALANINE AMINOTRANSFERASE INCREASED 27 0.0004
739 MYOCARDIAL ISCHAEMIA 5 0.0004
740 PRODUCT AVAILABILITY ISSUE 10 0.0004
741 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 31 0.0004
742 HIP FRACTURE 14 0.0004
743 PRODUCT DOSE OMISSION ISSUE 128 0.0004
744 NEOPLASM 5 0.0004
745 NASOPHARYNGITIS 80 0.0004
746 HYPOMAGNESAEMIA 6 0.0004
747 APHONIA 6 0.0004
748 WOUND 12 0.0004
749 MASS 6 0.0004
750 RENAL DISORDER 20 0.0004
751 BONE PAIN 25 0.0004
752 SPINAL PAIN 5 0.0004
753 HYPOXIA 15 0.0004
754 DRUG ADMINISTRATION ERROR 13 0.0004
755 PNEUMONIA 137 0.0004
756 MULTIPLE SCLEROSIS RELAPSE 29 0.0004
757 RESPIRATORY TRACT INFECTION 11 0.0004
758 SEPSIS 47 0.0004
759 IRRITABLE BOWEL SYNDROME 9 0.0004
760 SKIN DISORDER 14 0.0004
761 AGGRESSION 21 0.0004
762 PARALYSIS 6 0.0004
763 INCREASED APPETITE 8 0.0004
764 IMPAIRED QUALITY OF LIFE 6 0.0004
765 ELECTROCARDIOGRAM QT PROLONGED 15 0.0004
766 EYE PRURITUS 14 0.0004
767 THYROID CANCER 5 0.0004
768 CANDIDA INFECTION 7 0.0004
769 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 14 0.0004
770 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
771 MENTAL DISORDER 18 0.0004
772 INFLUENZA 46 0.0004
773 FLUID OVERLOAD 6 0.0004
774 APATHY 6 0.0004
775 NO THERAPEUTIC RESPONSE 5 0.0004
776 CYTOPENIA 5 0.0004
777 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
778 CARDIAC DISORDER 38 0.0004
779 EMOTIONAL DISTRESS 49 0.0004
780 SKIN EXFOLIATION 34 0.0004
781 RASH PAPULAR 9 0.0004
782 RESPIRATORY DISORDER 12 0.0004
783 ADVERSE DRUG REACTION 36 0.0004
784 INJECTION SITE DISCOLOURATION 5 0.0004
785 LEUKOPENIA 20 0.0004
786 SECRETION DISCHARGE 5 0.0004
787 TOXICITY TO VARIOUS AGENTS 67 0.0004
788 HEPATIC ENZYME INCREASED 27 0.0004
789 MEDICATION ERROR 22 0.0004
790 COLITIS 15 0.0004
791 LYMPHADENOPATHY 14 0.0004
792 DRUG INTOLERANCE 38 0.0004
793 MOBILITY DECREASED 28 0.0004
794 SYNOVITIS 7 0.0004
795 HAEMATOMA 10 0.0004
796 TREATMENT NONCOMPLIANCE 21 0.0004
797 NODULE 5 0.0004
798 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
799 CYANOSIS 6 0.0004
800 PANCREATIC CARCINOMA 11 0.0004
801 IMMUNE SYSTEM DISORDER 5 0.0004
802 THERAPEUTIC RESPONSE DECREASED 23 0.0004
803 DEPRESSED LEVEL OF CONSCIOUSNESS 15 0.0004
804 THROAT IRRITATION 17 0.0004
805 CYSTITIS 12 0.0004
806 DELIRIUM 13 0.0004
807 HALLUCINATION 28 0.0004
808 GASTRIC ULCER 7 0.0004
809 PRODUCT DOSE OMISSION 24 0.0004
810 LIVER INJURY 9 0.0004
811 HYPERSENSITIVITY 68 0.0004
812 DRUG INEFFECTIVE 482 0.0004
813 HEPATIC FAILURE 11 0.0004
814 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
815 GLAUCOMA 7 0.0004
816 CONTRAINDICATED PRODUCT ADMINISTERED 11 0.0004
817 EXTRAPYRAMIDAL DISORDER 9 0.0004
818 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
819 PNEUMONIA ASPIRATION 9 0.0004
820 COAGULOPATHY 6 0.0004
821 EAR PAIN 7 0.0004
822 STEVENS-JOHNSON SYNDROME 8 0.0004
823 RASH MACULO-PAPULAR 8 0.0004
824 ORAL HERPES 7 0.0004
825 INJECTION SITE PRURITUS 24 0.0004
826 GASTROINTESTINAL DISORDER 32 0.0004
827 SNEEZING 8 0.0004
828 FACE OEDEMA 6 0.0004
829 INCORRECT DRUG ADMINISTRATION DURATION 10 0.0004
830 CONDITION AGGRAVATED 108 0.0004
831 DISABILITY 7 0.0004
832 ASTHMA 40 0.0004
833 DRUG WITHDRAWAL SYNDROME 31 0.0004
834 APPLICATION SITE PRURITUS 8 0.0004
835 PYREXIA 122 0.0004
836 UPPER LIMB FRACTURE 7 0.0004
837 PARAESTHESIA ORAL 5 0.0003
838 MIGRAINE 33 0.0003
839 INJECTION SITE PAIN 106 0.0003
840 DEAFNESS 9 0.0003
841 BODY TEMPERATURE INCREASED 7 0.0003
842 COGNITIVE DISORDER 16 0.0003
843 INTENTIONAL PRODUCT USE ISSUE 30 0.0003
844 PANCYTOPENIA 19 0.0003
845 INJECTION SITE ERYTHEMA 42 0.0003
846 DRUG ERUPTION 6 0.0003
847 CARDIOMYOPATHY 5 0.0003
848 TOOTH LOSS 7 0.0003
849 DISEASE RECURRENCE 16 0.0003
850 INFECTION 48 0.0003
851 OSTEOMYELITIS 6 0.0003
852 VISUAL ACUITY REDUCED 11 0.0003
853 OSTEOPENIA 5 0.0003
854 PLEURAL EFFUSION 20 0.0003
855 ABNORMAL BEHAVIOUR 13 0.0003
856 INSURANCE ISSUE 5 0.0003
857 PROCEDURAL PAIN 9 0.0003
858 ABNORMAL WEIGHT GAIN 4 0.0003
859 LUNG INFECTION 5 0.0003
860 DISEASE PROGRESSION 38 0.0003
861 NERVOUS SYSTEM DISORDER 10 0.0003
862 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
863 HOSPITALISATION 49 0.0003
864 ABDOMINAL PAIN LOWER 8 0.0003
865 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
866 MUSCULOSKELETAL DISORDER 6 0.0003
867 DRY SKIN 42 0.0003
868 INJECTION SITE SWELLING 24 0.0003
869 CARDIO-RESPIRATORY ARREST 13 0.0003
870 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 22 0.0003
871 APPLICATION SITE ERYTHEMA 8 0.0003
872 SHOCK 7 0.0003
873 MANIA 5 0.0003
874 TACHYCARDIA 27 0.0003
875 PHOTOSENSITIVITY REACTION 5 0.0003
876 FEBRILE NEUTROPENIA 20 0.0003
877 ILLNESS 31 0.0003
878 NEOPLASM MALIGNANT 20 0.0003
879 PERICARDITIS 5 0.0003
880 ARRHYTHMIA 14 0.0003
881 CIRCULATORY COLLAPSE 5 0.0003
882 ADVERSE EVENT 27 0.0003
883 INJECTION SITE WARMTH 6 0.0003
884 ANAPHYLACTIC REACTION 16 0.0003
885 NEOPLASM PROGRESSION 10 0.0003
886 BONE DENSITY DECREASED 9 0.0003
887 NO ADVERSE EVENT 52 0.0003
888 HAEMORRHAGE 30 0.0003
889 HAEMOPTYSIS 8 0.0003
890 DEVICE USE ISSUE 5 0.0003
891 SEIZURE 33 0.0003
892 LUNG DISORDER 14 0.0003
893 ENCEPHALOPATHY 7 0.0003
894 INCORRECT DOSE ADMINISTERED 65 0.0003
895 DEVICE OCCLUSION 4 0.0003
896 DEPRESSED MOOD 15 0.0003
897 MOVEMENT DISORDER 9 0.0003
898 ILL-DEFINED DISORDER 17 0.0003
899 LIVER FUNCTION TEST INCREASED 6 0.0003
900 INJECTION SITE HAEMORRHAGE 22 0.0003
901 MELAENA 6 0.0003
902 LIVER DISORDER 12 0.0003
903 CONJUNCTIVITIS 5 0.0003
904 OSTEOPOROSIS 11 0.0003
905 HEPATIC CIRRHOSIS 5 0.0003
906 BONE LOSS 4 0.0003
907 INTESTINAL OBSTRUCTION 10 0.0003
908 HYPOCALCAEMIA 5 0.0003
909 FRACTURE 5 0.0003
910 BLOOD COUNT ABNORMAL 4 0.0003
911 DEVICE FAILURE 4 0.0003
912 FREQUENT BOWEL MOVEMENTS 7 0.0003
913 FEMUR FRACTURE 8 0.0003
914 PLASMA CELL MYELOMA 10 0.0003
915 SKIN FISSURES 5 0.0003
916 MENORRHAGIA 5 0.0003
917 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
918 PRODUCT PRESCRIBING ERROR 6 0.0003
919 INCORRECT ROUTE OF DRUG ADMINISTRATION 9 0.0003
920 TARDIVE DYSKINESIA 7 0.0002
921 INJURY ASSOCIATED WITH DEVICE 5 0.0002
922 DERMATITIS 5 0.0002
923 INJECTION SITE BRUISING 19 0.0002
924 ASCITES 7 0.0002
925 HEPATITIS 6 0.0002
926 GENERAL PHYSICAL HEALTH DETERIORATION 27 0.0002
927 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
928 VAGINAL HAEMORRHAGE 10 0.0002
929 SEPTIC SHOCK 10 0.0002
930 SEDATION 6 0.0002
931 INJECTION SITE RASH 7 0.0002
932 TRANSAMINASES INCREASED 5 0.0002
933 BREAST CANCER FEMALE 6 0.0002
934 PRODUCT USE ISSUE 42 0.0002
935 THERAPEUTIC PRODUCT EFFECT DECREASED 10 0.0002
936 BLINDNESS 9 0.0002
937 INTENTIONAL OVERDOSE 14 0.0002
938 PRODUCT USE IN UNAPPROVED INDICATION 54 0.0002
939 INJECTION SITE MASS 8 0.0002
940 OXYGEN SATURATION DECREASED 12 0.0002
941 OSTEONECROSIS 7 0.0002
942 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
943 PROSTATE CANCER 17 0.0002
944 INFUSION RELATED REACTION 14 0.0002
945 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
946 COMA 10 0.0002
947 OFF LABEL USE 181 0.0002
948 THROMBOCYTOPENIA 23 0.0002
949 OSTEONECROSIS OF JAW 5 0.0002
950 COLITIS ULCERATIVE 9 0.0002
951 DEVICE ISSUE 18 0.0002
952 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 11 0.0002
953 THERAPY NON-RESPONDER 9 0.0002
954 SUICIDE ATTEMPT 12 0.0002
955 EXPOSURE VIA SKIN CONTACT 5 0.0002
956 ECZEMA 10 0.0002
957 DERMATITIS ATOPIC 10 0.0002
958 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 38 0.0002
959 NEUTROPENIA 25 0.0002
960 EXPIRED PRODUCT ADMINISTERED 6 0.0002
961 MALIGNANT NEOPLASM PROGRESSION 18 0.0002
962 SKIN IRRITATION 8 0.0002
963 INJECTION SITE REACTION 12 0.0002
964 EXTRA DOSE ADMINISTERED 7 0.0002
965 BREAST CANCER 16 0.0002
966 ACNE 13 0.0002
967 PRODUCT ADHESION ISSUE 6 0.0002
968 DEATH 144 0.0002
969 UNDERDOSE 12 0.0002
970 ACCIDENTAL OVERDOSE 6 0.0002
971 EPILEPSY 5 0.0002
972 GYNAECOMASTIA 5 0.0002
973 CARDIOVASCULAR DISORDER 4 0.0002
974 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 28 0.0002
975 ANAPHYLACTIC SHOCK 4 0.0002
976 DEVICE BREAKAGE 6 0.0001
977 NEUTROPHIL COUNT DECREASED 6 0.0001
978 DEVICE MALFUNCTION 10 0.0001
979 CARDIAC FAILURE 10 0.0001
980 LUNG NEOPLASM MALIGNANT 5 0.0001
981 DEVICE LEAKAGE 5 0.0001
982 DEVICE DISLOCATION 5 0.0001
983 OVERDOSE 24 0.0001
984 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
985 C-REACTIVE PROTEIN INCREASED 4 0.0001
986 INTERSTITIAL LUNG DISEASE 5 0.0001
987 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
988 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
989 DRUG DEPENDENCE 11 0.0001
990 BLADDER CANCER 4 0.0001
991 TREATMENT FAILURE 5 0.0001
992 DRUG ABUSE 5 0.0001